Receptor tyrosine kinases: the main targets for new anticancer therapy
Current drug targets, 2003 - ingentaconnect.com
Because conventional chemotherapy is not specific for cancer cells leading to toxic side
effects there is a need for novel agents with high grade antitumor specificity. The major …
effects there is a need for novel agents with high grade antitumor specificity. The major …
Receptor tyrosine kinases: the main targets for new anticancer therapy
J Drevs, M Medinger… - Current drug …, 2003 - pubmed.ncbi.nlm.nih.gov
Because conventional chemotherapy is not specific for cancer cells leading to toxic side
effects there is a need for novel agents with high grade antitumor specificity. The major …
effects there is a need for novel agents with high grade antitumor specificity. The major …
Receptor tyrosine kinases: the main targets for new anticancer therapy
J Drevs, M Medinger, C Schmidt-Gersbach… - Current Drug …, 2003 - edoc.unibas.ch
Because conventional chemotherapy is not specific for cancer cells leading to toxic side
effects there is a need for novel agents with high grade antitumor specificity. The major …
effects there is a need for novel agents with high grade antitumor specificity. The major …
[引用][C] Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
J Drevs, M Medinger, C Schmidt-Gersbach… - Current Drug …, 2003 - cir.nii.ac.jp
Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Receptor tyrosine kinases: the main targets for new anticancer therapy.
J Drevs, M Medinger, C Schmidt-Gersbach… - Current Drug …, 2003 - europepmc.org
Because conventional chemotherapy is not specific for cancer cells leading to toxic side
effects there is a need for novel agents with high grade antitumor specificity. The major …
effects there is a need for novel agents with high grade antitumor specificity. The major …